TrivarX Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDBIF research report →
Companytrivarx.com
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023.
- CEO
- Kai Sun
- IPO
- 2017
- Employees
- 6
- HQ
- Mount Lawley, WA, AU
Price Chart
Valuation
- Market Cap
- $1.62M
- P/E
- -14.83
- P/S
- 0.00
- P/B
- 1.11
- EV/EBITDA
- -16.54
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -7.84%
- ROIC
- -7.25%
Growth & Income
- Revenue
- $1.13M · 27.02%
- Net Income
- $-943,231 · 23.75%
- EPS
- $-0.00 · 52.50%
- Op Income
- $128.25K
- FCF YoY
- 95.17%
Performance & Tape
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 0.83
- Avg Volume
- 12
Get TickerSpark's AI analysis on MDBIF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MDBIF Coverage
We haven't published any research on MDBIF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MDBIF Report →